Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1982-12-27
1985-03-26
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544408, 544409, C07D24116, A01N 4360
Patent
active
045072990
ABSTRACT:
Antimicrobial compounds of the formula: ##STR1## wherein: Hal is bromine or chlorine;
REFERENCES:
patent: 3274192 (1966-09-01), Cragoe et al.
patent: 3299063 (1967-01-01), Cragoe et al.
patent: 3341540 (1967-09-01), Cragoe et al.
patent: 3487082 (1969-12-01), Cragoe et al.
patent: 3626060 (1971-12-01), Grier
patent: 3763176 (1973-10-01), Kohn et al.
patent: 3854000 (1974-12-01), Kohn et al.
patent: 4054655 (1977-10-01), Donald
patent: 4119779 (1978-10-01), Grier et al.
patent: 4145426 (1979-03-01), Grier et al.
Albert and Clark, J.C.S. 1666-1673, (1964).
Coughlan, Jr. Paul M.
Merck & Co. , Inc.
Olson R. Brent
Speer Raymond M.
Teoli, Jr. William A.
LandOfFree
N-[2-amino-5-halo-6-(substituted)-3-pyrazinyl)-methylene]amine a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-[2-amino-5-halo-6-(substituted)-3-pyrazinyl)-methylene]amine a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-[2-amino-5-halo-6-(substituted)-3-pyrazinyl)-methylene]amine a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1293762